Onderneming Jilin Aodong Pharmaceutical Group Co., Ltd.
Aandelen
000623
CNE000000719
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
14,89 CNY | -2,30% | +1,36% | -1,65% |
Vakgebied
- verkoop van farmaceutische producten (89,4%);
- verkoop van levensmiddelen (6,8%);
- overig (3,8%).
Alle verkopen vinden plaats in China.
Aantal werknemers: 5 646
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Medicine
76,6
%
| 2 150 | 74,9 % | 2 643 | 76,6 % | +22,97% |
Food
11,2
%
| 377 | 13,1 % | 386 | 11,2 % | +2,50% |
Wholesale and Retail of Chain Drug Stores
10,9
%
| 450 | 15,7 % | 377 | 10,9 % | -16,17% |
Other
7,8
%
| 202 | 7,0 % | 268 | 7,8 % | +32,57% |
Inter-segment Elimination
-6,6
%
| -312 | -10,9 % | -227 | -6,6 % | -27,21% |
Group Investment
0,1
%
| 2 | 0,1 % | 2 | 0,1 % | -7,40% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 2 868 | 100,0 % | 3 449 | 100,0 % | +20,26% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shu Qin Guo
CEO | Chief Executive Officer | 61 | 01-01-98 |
Kai Yang
DFI | Director of Finance/CFO | 47 | 01-05-04 |
Da Long Zhao
DFI | Director of Finance/CFO | 50 | 01-07-99 |
Shu Yuan Zhang
DFI | Director of Finance/CFO | 52 | 18-06-07 |
Yong Feng Chen
CHM | Chairman | 57 | 01-10-00 |
Ming Jing Zhang
BRD | Director/Board Member | 42 | 01-07-17 |
Zhen Yu Wang
BRD | Director/Board Member | 43 | 01-07-04 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Xiu Lin Li
CHM | Chairman | 71 | 01-02-93 |
Shu Qin Guo
CEO | Chief Executive Officer | 61 | 01-01-98 |
Yong Feng Chen
CHM | Chairman | 57 | 01-10-00 |
Gang Xiu
BRD | Director/Board Member | 58 | 01-02-06 |
Peng Li
BRD | Director/Board Member | 42 | 17-07-20 |
Da Long Zhao
BRD | Director/Board Member | 50 | 01-01-16 |
Kai Yang
DFI | Director of Finance/CFO | 47 | 01-05-04 |
Ming Jing Zhang
BRD | Director/Board Member | 42 | 01-07-17 |
An Ning Li
BRD | Director/Board Member | 38 | 04-01-22 |
Wei Wei Xiao
BRD | Director/Board Member | 44 | 09-09-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 241 069 418 | 811 810 642 ( 65,41 %) | 45 174 031 ( 3,640 %) | 65,41 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
GF SECURITIES CO., LTD. 15.06% | 256 290 400 | 15.06% | 264 919 698 $ |
91 500 376 | 5.98% | 128 500 383 $ | |
36 138 251 | 3.12% | 72 302 160 $ |
Bedrijfsgegevens
Jilin Aodong Pharmaceutical Group Co., Ltd.
2158 Aodong Street Dunhua
133700, Yanbian Korean Autonomous Prefecture
+
http://www.jlaod.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,65% | 2,46 mld. | |
+33,25% | 704 mld. | |
+28,59% | 577 mld. | |
-3,55% | 348 mld. | |
+18,16% | 327 mld. | |
+4,36% | 288 mld. | |
+14,81% | 234 mld. | |
+4,93% | 198 mld. | |
-9,78% | 194 mld. | |
-3,69% | 147 mld. |
- Beurs
- Aandelen
- Koers 000623
- Onderneming Jilin Aodong Pharmaceutical Group Co., Ltd.